Literature DB >> 21777038

The use of in vitro systems to assess cancer mechanisms and the carcinogenic potential of chemicals.

Damien Breheny1, Oluwatobiloba Oke, Stephen P Faux.   

Abstract

Carcinogenesis is a highly complex, multi-stage process that can occur over a relatively long period before its clinical manifestation. While the sequence in which a cancer cell acquires the necessary traits for tumour formation can vary, there are a number of mechanisms that are common to most, if not all, cancers across the spectrum of possible causes. Many aspects of carcinogenesis can be modelled in vitro. This has led to the development of a number of mechanistically driven, cell-based assays to assess the pro-carcinogenic and anti-carcinogenic potential of chemicals. A review is presented of the current in vitro models that can be used to study carcinogenesis, with examples of cigarette smoke testing in some of these models, in order to illustrate their potential applications. We present an overview of the assays used in regulatory genotoxicity testing, as well as those designed to model other aspects that are considered to be hallmarks of cancer. The latter assays are described with a view to demonstrating the recent advances in these areas, to a point where they should now be considered for inclusion in an overall testing strategy for chemical carcinogens. 2011 FRAME.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21777038     DOI: 10.1177/026119291103900301

Source DB:  PubMed          Journal:  Altern Lab Anim        ISSN: 0261-1929            Impact factor:   1.303


  3 in total

1.  Characterisation of an aerosol exposure system to evaluate the genotoxicity of whole mainstream cigarette smoke using the in vitro γH2AX assay by high content screening.

Authors:  Carolina Garcia-Canton; Graham Errington; Arturo Anadon; Clive Meredith
Journal:  BMC Pharmacol Toxicol       Date:  2014-07-23       Impact factor: 2.483

2.  A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells.

Authors:  Eleanor C Wilde; Katherine E Chapman; Leanne M Stannard; Anna L Seager; Katja Brüsehafer; Ume-Kulsoom Shah; James A Tonkin; M Rowan Brown; Jatin R Verma; Ann T Doherty; George E Johnson; Shareen H Doak; Gareth J S Jenkins
Journal:  Arch Toxicol       Date:  2017-11-06       Impact factor: 6.168

3.  Multiple-endpoint in vitro carcinogenicity test in human cell line TK6 distinguishes carcinogens from non-carcinogens and highlights mechanisms of action.

Authors:  Katherine E Chapman; Eleanor C Wilde; Fiona M Chapman; Jatin R Verma; Ume-Kulsoom Shah; Leanne M Stannard; Anna L Seager; James A Tonkin; M Rowan Brown; Ann T Doherty; George E Johnson; Shareen H Doak; Gareth J S Jenkins
Journal:  Arch Toxicol       Date:  2020-09-10       Impact factor: 6.168

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.